#cardiovascularrisks
Explore tagged Tumblr posts
Text
Unravel the mysteries of smoking's impact on vascular health. Gain valuable insights into the correlation between smoking and vascular diseases, and the serious cardiovascular risks posed by this habit.
#smokingeffects#vascularhealth#vasculardiseases#cardiovascularrisks#quitsmokingnow#hearthealthmatters#healthyvascularsystem#notosmoking#heartdiseaseawareness#healthyhearthabits
2 notes
·
View notes
Photo
What is Cardiovascular Health? https://healthsnbeauty.com/what-is-cardiovascular-health/?utm_source=tumblr&utm_medium=social&utm_campaign=Health+%26+Beauty+tips
#cardiovasculardiseaseprevention#cardiovascularrisk#cardiovasculardiseasesymptoms#cardiovasculardisease#cardiovasculardiseaseoverview#cardiovasculardeath#cardiovasculardiseasetips#cardiovascular
0 notes
Text
0 notes
Text
👨⚕️ How Stress Damages the Heart: Key Risks to Consider
Stress is not just a mental burden; it has profound effects on your heart as well. Here’s how stress can damage your heart:
Risk of Heart Attack: 40% Chronic stress can increase the risk of a heart attack by 40%, as stress hormones elevate blood pressure and lead to unhealthy behaviors like poor diet and smoking.
Risk of Heart Disease: 30% The prolonged impact of stress raises the risk of developing heart disease by 30%, making it crucial to manage stress effectively.
High Blood Pressure: 70% Stress contributes to a 70% higher risk of developing high blood pressure, a leading cause of heart disease and stroke.
Heart Rate and Rhythm Issues: 25% Stress can cause irregular heartbeats and other rhythm issues, increasing the risk by 25%. This can lead to serious complications if not addressed.
Inflammation: 35% Stress triggers inflammation in the body, increasing the risk of heart-related issues by 35%. Chronic inflammation is a key player in the development of cardiovascular diseases.
Understanding these risks highlights the importance of managing stress to protect your heart. For expert advice on heart health, you can consult Dr. Md. Farhan Shikoh, MBBS, MD (Medicine), DM (Cardiology) at Sukoon Heart Care, Sainik Market, Main Road, Ranchi, Jharkhand: 834001. For appointments, call 6200784486 or visit drfarhancardiologist.com.
#HeartHealth#StressAndHeart#CardiovascularRisk#HeartAttackPrevention#ManageStress#HighBloodPressure#CardiacCare#HeartDiseaseAwareness#InflammationRisks#HeartHealthTips#HealthyHeart#HeartRateIssues#StressManagement#HeartRhythm#HeartHealthMatters#CardiologistAdvice#RanchiHealthcare#HeartCare#HeartWellness#DrFarhanShikoh
1 note
·
View note
Text
Obesity Beyond the Surface
Obesity’s Silent Onset: Unraveling the Health Implications” The health implications of obesity extend beyond the physical appearance. Individuals with obesity face an elevated risk of developing chronic diseases such as hypertension, hyperlipidemia, and sleep apnea. Moreover, obesity is a recognized risk factor for certain cancers, including breast, colorectal, and prostate cancers, highlighting…
View On WordPress
0 notes
Photo
Did you know that losing your sense of smell could be a sign of an impending heart failure? - Loss of smell may indicate neurodegenerative diseases and potentially heart failure risk. - Heart failure affects millions due to various factors like hypertension and smoking. - Study shows a 30% higher risk of heart failure in people with anosmia. - Possible reasons behind the link include stress vulnerability and lifestyle impact. - Olfactory tests could help detect heart failure risk early and guide preventive measures. Join the holistic healthcare approach to tackle cardiovascular issues effectively. Find out more at mon-quotidien.fr #HeartHealth #OlfactoryHealth #Prevention #CardiovascularRisk #HealthResearch
0 notes
Text
Do artificial sweeteners increase cardiovascular risk?
Elevated levels of artificial sweeteners were associated with the risk for cardiovascular events, studies show
#ArtificialSweeteners #CardiovascularRisk
#heart #sugar
-https://www.nih.gov/news-events/nih-research-matters/erythritol-cardiovascular-events#:~:text=The%20team%20found%20that%20elevated,and%20Europe%20totaling%20almost%203%2C000.
-https://www.medscape.com/viewarticle/artificial-sweeteners-increase-cardiovascular-risk-2023a1000jjg
instagram
0 notes
Text
COVID-19 in kids: what data about admissions, seriousness and complications are there?
Children with SARS-CoV2 infection show a broad range of clinical presentations, from asymptomatic to a critical or fatal infection. In most cases, respiratory symptoms, fever, and in some cases, diarrhea, fever, and loss of smell, are typical. Some children develop severe inflammatory sequelae involving multiple organ systems, called the multisystem inflammatory syndrome in children (MIS-C). PIMS or MIS-C usually occurs 2 to 6 weeks after SARS-CoV-2 infection, and the most common symptom in all affected children is persistent fever, while other clinical features such as acute abdominal pain, muscle pain, diarrhea or vomiting, headache, and fatigue vary across affected children. Hyperemia and exanthema, a “strawberry tongue” and swollen hands and feet resembling Kawasaki´s disease have been seen in a high proportion of PIMS/MIS-C patients. Cardiovascular issues such as myocardial dysfunction, arterial hypotension, or systemic shock have also been regularly seen, while myocarditis, pericarditis, and valve and coronary artery involvement may also develop. Lab analyses show intensive inflammation with elevated levels of serum C-reactive protein, ferritin, procalcitonin, troponin, and markers of coagulopathy and hematologic abnormalities. Most children affected by PIMS will need ICU care due to multiorgan failure and shock. Studies have discussed a possible involvement of pathogenetically relevant autoantibodies in MIS-C. Scientists recently discovered neutralizing autoantibodies against the IL-1-receptor antagonist (IL-1-Ra) and anti-inflammatory receptor antagonists progranulin (PGRN) in adult patients with severe COVID-19. While risk factors for hospitalization and poor outcomes are well documented in adults, less is known about the clinical factors associated with COVID disease severity in children. In an effort to aid mitigation strategies for children who are at high risk of developing severe COVID disease, a group of physicians at Monroe Carell Jr. Children's Hospital at Vanderbilt studied data from 45 children's hospitals around the country; overall 20.000 patients were included. The study, published in the Journal of Hospital Medicine, determined the factors associated with severe disease and poor health outcomes among children presenting to the hospital with COVID. These included older age and chronic co-morbidities such as obesity, diabetes and neurologic conditions, among others. The retrospective cohort study noted that approximately 1 out of every 4 children admitted to the hospital with COVID developed severe disease and required ICU care during April and September, 2020. Since most reports on SARS-CoV2 infection in children are based on cohorts of hospitalized children, leading to the full spectrum of disease having escaped description. The current report focuses on social and demographic characteristics of the pediatric population, along with the clinical phenotypes, symptom duration, and outcomes in this population. The initial period of the pandemic did not seriously affect children partly due to their relative isolation from sources of infection via school closures. However, the delta variant of SARS-CoV2 that is currently spreading has affected children more than that initial period. This is why a reasearch in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19. This led to the identification of risk factors for hospitalization. The study took place in a large pediatric hospital in the southeast of the USA. The researchers found that the first thousand pediatric patients with SARS-CoV2 infection were enrolled in hospital records between March 13 and September 28 in 2020. Almost two-thirds of these children had close contact with a known infected individual. About one in five had another medical condition. While 80% of tests were in the outpatient setting, the remaining were from the emergency department, with a small fraction being returned after admission. The median period from symptom onset to testing was two days. More than half the children presented with cough, while 43% had a headache. A little more than one in three had a sore throat, with a similar proportion reporting fever. Younger children had fever and rash more often, but older children more often reported sore throat and muscle pains. In this group, 75% of children had one or more symptoms connected to the respiratory system, two-thirds had a general symptom, and just over a quarter had gut symptoms. Respiratory symptoms included cough, runny nose, sore throat, or difficulty in breathing. In two-thirds of the respiratory-symptom group, these were accompanied by one or more general symptoms such as headache, muscle pain, anosmia, fatigue, or a rash. A quarter had respiratory symptoms and one gut-related symptom such as nausea/vomiting, diarrhea and abdominal pain. About 4% of the patients required hospitalization, two-thirds of hospitalized children had another medical condition. Fewer than 1% (eight children) needed intensive care unit (ICU) admission, and two children needed mechanical ventilation. Only one child later developed MIS-C, and there was one death in the whole group, possibly due to the infection. About 45% of children reported complete recovery at a median of two days from diagnosis. Older children were more likely to have continuing symptoms at this time. Most children (94%) recovered from their symptoms within a month. At 30 days, there were 28 patients with symptoms like tiredness, fatigue, and reduced smell sensation. There were no instances of long COVID-19 in this cohort. According to their analysis, the presence of another medical condition increased the risk of hospitalization almost eight times, while shortness of breath increased it seven times. The presence of vomiting increased the risk by five times. Black or Hispanic origin was associated with an increase by three times. The studies demonstrated that most children with SARS-CoV2 infection had favorable outcomes, did not require hospitalization, and often recovered within two days of diagnosis. The reason for this difference in the severity between adults and children is unknown. The increased expression of the host cofactor TMPRSS2 in lung cells with age may be one explanation. Despite the lower susceptibility to infection and severe disease, it remains true that three million children have been infected in the USA so far. Hispanic children, and those with infected siblings, are at higher risk. Such considerations may drive mitigation strategies. The mildness of infection in this age group means that the extent to which children drive household transmission is not yet established. The impact of school closures on the viral spread from children to adults may thus not be as effective as envisaged. The risk factors for hospitalization differ between children and adults. In the latter, being male, older, and obese increases the risk of severe COVID-19. However, obesity and male sex were not found to be risk factors for hospitalization in children. Hispanic or Black ethnicity, vomiting, having another medical condition or presenting with dyspnea predicted a higher risk of severe disease. Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry. Scientific references Howard L et al. BMC Pediatrics 2021; 21(1):403. Pfeider J et al. medRxiv 2021 Sept 8; 21263027. Antoon JW et al. J Hosp Med 2021; 16(5):294-97. Read the full article
#autoantibodies#autoimmunity#biomarkers#C-reactiveprotein#cardiovascularrisk#coagulation#coronavirus#hospitalization#intensivecareunit#myocarditis#pandemic#pediatrics#respiratorydisease#viralinfection
0 notes
Text
Tweeted
Participants needed for online survey! Topic: "Sleep Disorders and Cardiovascular Risk" https://t.co/OXk8oXSQBE via @SurveyCircle #SleepDisorders #insomnia #ObstructiveSleepApnoea #CardiovascularRisk #cvd #survey #surveycircle https://t.co/ly4LREd5Gc
— Daily Research @SurveyCircle (@daily_research) Jul 27, 2022
0 notes
Text
Tweeted
RT @newlifemedicine: Find out how you can decrease your #cardiovascularrisks factors with life style changes. Call #NewLifeMedicine at (405)265-2610 or visit https://t.co/xlEVH0RcD9 to start your journey to a #healthyheart.#IlonaSamara #functionalmedic… pic.twitter.com/L5iIdPVAe2
— Eddy Bettermann 🇩🇪 (@DrEddyMD) May 4, 2018
0 notes
Photo
Saltare la colazione aumenta il rischio cardiovascolare! #breakfast #colazione #cardiologo #cardiology #cardiovascularrisk #breakfastskipper #hypertension #simf #medicinadisegnale #medicinanaturale #salusproject (presso Carlo Maggio)
#breakfastskipper#cardiovascularrisk#salusproject#medicinadisegnale#breakfast#cardiologo#medicinanaturale#hypertension#cardiology#simf#colazione
0 notes
Text
Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Systemic lupus erythematosus (SLE), is a heterogeneous disease which predominantly affects young females (90%). SLE is associated with a shorter life expectancy than in the general population. Standardized mortality ratios (SMR) of 2.4 have been reported, which is comparable to diabetes. In modern societies cardiovascular disease (CVD) is the major cause of premature mortality. Accelerated atherosclerosis is generally assumed to be the underlying cause for SLE related CVD. However, previous studies diverge regarding whether atherosclerosis is more common in SLE than in controls.
Hypothesis >> accelerated atherosclerosis is not a general feature of SLE, but prevails in SLE subgroups.
PLoS ONE, april 2017
281 SLE patients and 281 individually age and sex matched population controls, were investigated clinically. Fasting blood samples and risk factor data were collected. All participants were subject to B-mode ultrasonography of the carotid arteries. Carotid plaque occurrence and mean intima media thickness (mIMT) were recorded. Two SLE subgroups previously described to be at high CVD risk; 1) patients with nephritis and 2) patients with anti-phospholipid antibodies (aPL), and one subgroup reported to be at comparatively lower CVD risk; patients positive for Sjögren´s syndrome antigens A/B (SSA/SSB) antibodies were analyzed separately in comparison with their respective matched controls.
Results
Median age was 49 (IQR 36–59) years, 93% were females. Manifest CVD; ischemic heart, cerebro- and peripheral vascular disease, prevailed in patients (12% vs. 1%, p<0.0001). Overall plaque prevalence did not differ (20% vs. 16%), but patients had slightly higher mIMT than controls (0.56 vs. 0.53 mm, p<0.0033). After age adjustment plaques, but not mIMT, remained associated with previous CVD events. Therefore we focused further analyses on plaques, a more robust measure of atherosclerosis. Patients with nephritis (40%), but neither aPL (25%) nor SSA/SSB (40%) positive patients, had more plaques than their respective controls (23% vs. 11%, p = 0.008). Notably, patients with nephritis were younger than other SLE patients (45 vs.49 years, p = 0.02). To overcome the confounding effect of age we performed an age-matched nested case-control analysis, which demonstrated that patients with nephritis had twice as often plaques (23%) as both non-nephritis patients (11%, p = 0.038) and controls (12%, p = 0.035).
Conclusions
In SLE excess carotid plaques are essentially confined to the SLE subgroup with nephritis. This subgroup had plaques twice as often as age-matched non-nephritis SLE patients and population controls. Non-nephritis SLE patients, including the aPL positive subgroup, which has a high CVD risk, had similar prevalence of plaques as controls. To prevent later CVD events, this novel observation calls for risk factor screening and initiation of anti-atherosclerotic treatment selectively in SLE nephritis patients. Preferably at nephritis onset, which is often at a young age. In a general perspective this study demonstrates the importance to perform careful clinical subgroup analyses when investigating heterogeneous, hitherto not clearly defined, conditions like SLE.
0 notes
Photo
What is Cardiovascular Health? https://healthsnbeauty.com/what-is-cardiovascular-health/?utm_source=tumblr&utm_medium=social&utm_campaign=Health+%26+Beauty+tips
#cardiovascularrisk#cardiovascular#cardiovasculardiseaseprevention#cardiovasculardiseaseoverview#cardiovasculardiseasesymptoms#cardiovasculardiseasetips#cardiovasculardeath#cardiovasculardisease
0 notes
Text
Cardiovascular DiseaseObesity is an important determinant of cardiovascular dis
Cardiovascular DiseaseObesity is an important determinant of cardiovascular dis
Cardiovascular DiseaseObesity is an important determinant of cardiovascular diseasebecause it directly affects several established cardiovascularrisk factors, including hypertension and diabetes.It is estimated that the average weight for an 18-year-oldwoman is 123 lbs. and increases to 142 lbs. at 50 yearsof age. Also, let us assume that the average SBP for a50-year-old woman is 125 mm Hg, with…
View On WordPress
0 notes
Photo
What is Cardiovascular Health? https://healthsnbeauty.com/what-is-cardiovascular-health/?utm_source=tumblr&utm_medium=social&utm_campaign=Health+%26+Beauty+tips
#cardiovasculardiseaseprevention#cardiovascular#cardiovasculardisease#cardiovasculardiseaseoverview#cardiovasculardiseasesymptoms#cardiovasculardiseasetips#cardiovasculardeath#cardiovascularrisk
0 notes
Photo
What is Cardiovascular Health? https://healthsnbeauty.com/what-is-cardiovascular-health/?utm_source=tumblr&utm_medium=social&utm_campaign=Health+%26+Beauty+tips
#cardiovascularrisk#cardiovasculardisease#cardiovasculardiseaseoverview#cardiovasculardiseasesymptoms#cardiovasculardiseasetips#cardiovasculardiseaseprevention#cardiovascular#cardiovasculardeath
0 notes